Literature DB >> 9594364

Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.

A Vacca1, D Ribatti, M Iurlaro, A Albini, M Minischetti, F Bussolino, A Pellegrino, R Ria, M Rusnati, M Presta, V Vincenti, M G Persico, F Dammacco.   

Abstract

Human lymphoproliferative diseases can be hypothesized to invade locally and to metastatize via mechanisms similar to those developed by a variety of solid tumors, i.e., the secretion of extracellular matrix-degrading enzymes and stimulation of angiogenesis. To assess this hypothesis, Namalwa, Raji, and Daudi cell lines (Burkitt's lymphoma), LIK and SB cell lines (B-cell lymphoblastic leukemia), CEM and Jurkat cell lines (T-cell lymphoblastic leukemia), and U266 cell line (multiple myeloma) were evaluated for their capacity to produce matrix metalloproteinase-2 and -9, and urokinase-type plasminogen activator. These cell lines were also assessed for their ability: (1) to produce the angiogenic basic fibroblast growth factor and vascular endothelial growth factor; (2) to induce an angiogenic phenotype in cultured endothelial cells, represented by cell proliferation, chemotaxis, and morphogenesis; (3) to stimulate angiogenesis in different in vivo experimental models. All cell lines expressed the mRNA for one or both metalloproteinases. Namalwa, Raji, LIK, SB, and U266 cells secreted the active form of both metalloproteinases, while Daudi, CEM, and Jurkat cells produced metalloproteinase-2 but not-9. In contrast, urokinase-type plasminogen activator was secreted only by SB cells. While Raji, LIK, SB, CEM, and Jurkat cells secreted both basic fibroblast growth factor and vascular endothelial growth factor, Daudi and U266 cells produced only the former, and Namalwa cells only the latter. Accordingly, the conditioned medium of all cell lines stimulated cell proliferation and/or chemotaxis in cultured endothelial cells, with the exception of that of Namalwa cells which was ineffective. The conditioned medium of CEM and Jurkat cells induced morphogenesis in cultured endothelial cells grown on a reconstituted basement membrane (Matrigel). Lastly, Namalwa, Raji, LIK, SB, U266, CEM, and Jurkat cells induced angiogenesis and mononuclear cell recruitment in the murine Matrigel sponge model and in a chick embryo chorioallantoic membrane assay. The extent of angiogenesis in both models was strictly correlated with the density of the mononuclear cell infiltrate. The results indicate that human lymphoproliferative disease cells possess both local and remote invasive ability via the secretion of matrix-degrading enzymes and the induction of angiogenesis which is fostered by host inflammatory cells and by an intervening ensemble of angiogenic factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9594364     DOI: 10.1007/s005990050018

Source DB:  PubMed          Journal:  Int J Clin Lab Res        ISSN: 0940-5437


  16 in total

Review 1.  Angiogenesis in hematologic malignancies and its clinical implications.

Authors:  Renchi Yang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis.

Authors:  Alanna Ruddell; Pau Mezquita; Kimberly A Brandvold; Andrew Farr; Brian M Iritani
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

3.  Hypoxia inducible factor-1 alpha and multiple myeloma.

Authors:  Archana Bhaskar; Bhupendra Nath Tiwary
Journal:  Int J Adv Res (Indore)       Date:  2016-01-01

4.  Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines.

Authors:  Gregory K Hong; Pawan Kumar; Ling Wang; Blossom Damania; Margaret L Gulley; Henri-Jacques Delecluse; Peter J Polverini; Shannon C Kenney
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Tax 1-independent induction of vascular endothelial growth factor in adult T-cell leukemia caused by human T-cell leukemia virus type 1.

Authors:  Karen M Watters; Jonathan Dean; Virginie Gautier; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

6.  A murine model of myeloma that allows genetic manipulation of the host microenvironment.

Authors:  Jessica A Fowler; Gregory R Mundy; Seint T Lwin; Conor C Lynch; Claire M Edwards
Journal:  Dis Model Mech       Date:  2009-09-24       Impact factor: 5.758

7.  Vascular endothelial growth factor levels in childhood acute lymphoblastic and myeloblastic leukemia.

Authors:  Göksel Leblebisatan; Bülent Antmen; Ilgen Saşmaz; Yurdanur Kilinç
Journal:  Indian J Hematol Blood Transfus       Date:  2011-08-17       Impact factor: 0.900

Review 8.  Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors.

Authors:  Li Chen; Alexander Endler; Futoshi Shibasaki
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

Review 9.  The role of angiogenesis in human non-Hodgkin lymphomas.

Authors:  Domenico Ribatti; Beatrice Nico; Girolamo Ranieri; Giorgina Specchia; Angelo Vacca
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

10.  The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models.

Authors:  Yousef Salama; Andries Hendrik Heida; Kazuaki Yokoyama; Satoshi Takahashi; Koichi Hattori; Beate Heissig
Journal:  Blood Adv       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.